PAVmed Inc
General ticker "PAVM" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $8.7M
PAVmed Inc does not follow the US Stock Market performance with the rate: -38.6%.
Estimated limits based on current volatility of 10.2%: low 0.59$, high 0.72$
Factors to consider:
- Current price 71.8% below estimated low
- Earnings for 18 months up through Q2 (+1 year) are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [3.69$, 12.28$]
- 2023-12-31 to 2024-12-30 estimated range: [2.29$, 7.41$]
Financial Metrics affecting the PAVM estimates:
- Negative: Non-GAAP EPS, $ of -9.15 <= 0.10
- Negative: Operating profit margin, % of -99.59 <= 1.03
- Negative: Operating cash flow per share per price, % of -57.18 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -7.05 <= 3.85
- Negative: Industry inventory ratio change (median), % of 2.06 > 0.49
Short-term PAVM quotes
Long-term PAVM plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.50MM | $0.38MM |
| Operating Expenses | $23.35MM | $54.89MM | $91.30MM |
| Operating Income | $-23.35MM | $-54.39MM | $-90.93MM |
| Non-Operating Income | $-12.54MM | $-1.73MM | $-12.31MM |
| Interest Expense | $0.05MM | $0.00MM | $1.27MM |
| R&D Expense | $10.96MM | $19.85MM | $25.55MM |
| Income(Loss) | $-35.89MM | $-56.13MM | $-103.24MM |
| Taxes | $-1.56MM | $-5.78MM | $-1.94MM |
| Profit(Loss) | $-34.33MM | $-50.35MM | $-101.29MM |
| Stockholders Equity | $1.90MM | $61.67MM | $-9.68MM |
| Inventory | $0.85MM | $4.65MM | $0.26MM |
| Assets | $19.78MM | $86.98MM | $53.98MM |
| Operating Cash Flow | $-21.91MM | $-40.59MM | $-70.98MM |
| Capital expenditure | $0.06MM | $1.47MM | $1.54MM |
| Investing Cash Flow | $-0.06MM | $-3.72MM | $-4.74MM |
| Financing Cash Flow | $33.01MM | $104.31MM | $38.21MM |
| Earnings Per Share* | $-10.93 | $-9.80 | $-15.03 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.